MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image BEACON THERAPEUTICS
BEACON THERAPEUTICS

BEACON THERAPEUTICS

Summary

Beacon Therapeutics is a gene therapy company dedicated to developing treatments for blinding retinal diseases.

Deals Overview

Total Deals3
Valued Deals2
Total Value£ 230 M
Avg. Deal Size£ 115 M

Market Context

Sort

12 Jun 2023|United States|Health Care Services
Beacon Therapeutics
Syncona

Target: BEACON THERAPEUTICS

Bidder: SYNCONA LTD

3 Service Providers

1 Target | 2 Bidder

8 Dealmakers

2 Target | 6 Bidder

£ 96 M

Value

09 Apr 2024|United States|Biotechnology
Beacon Therapeutics (contract, Manufacturing And Controls Team)
Ascend Advanced Therapies

Target: BEACON THERAPEUTICS (CONTRACT, MANUFACTURING AND CONTROLS TEAM)

Bidder: ASCEND ADVANCED THERAPIES

6 Service Providers

4 Bidder | 2 Vendor

16 Dealmakers

12 Bidder | 4 Vendor

n/a

Value

03 Jul 2024|United States|Health Care Services
Beacon Therapeutics
Syncona

Target: BEACON THERAPEUTICS

Bidder: SYNCONA LTD

9 Service Providers

3 Target | 6 Bidder

10 Dealmakers

1 Target | 9 Bidder

£ 134 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - BEACON THERAPEUTICS